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To what extent is multi-morbidity
associated with new onset depression in
patients attending cardiac rehabilitation?
Serdar Sever1* , Patrick Doherty2, Alexander Stephen Harrison2 and Su Golder2
Abstract
Background: Depression is associated with increased mortality and poor prognosis in patients with cardiovascular
disease (CVD). However, little is known about the patient characteristics associated with new onset post heart event
depressive symptoms, specifically medical comorbidities, among cardiac rehabilitation (CR) participants. Therefore,
this paper examines the comorbidity profile and characteristics associated with new onset depressive symptoms in
patients attending CR.
Methods: An observational study using the routine practice data of British Heart Foundation National Audit of
Cardiac Rehabilitation (NACR) from the last six years between April 2012 and March 2018. Patients with new onset
post heart event depression and no previous documented history of depression were selected as the study
population. An independent samples t-test and chi square tests were used to compare the association between
new onset depressive symptoms and patient variables including demographics, clinical measures and comorbidities. A
binary logistic regression was conducted to investigate the predictors of new onset depressive symptoms employing
log-likelihood ratio statistic.
Results: The analyses included 109,055 CR patients with new onset depression measured by Hospital Anxiety and
Depression Scale (HADS). At baseline assessment, comorbidity measures associated with new onset depressive
symptoms were increased total number of comorbidities and a range of comorbidities - including diabetes, angina,
arthritis, chronic back problems, asthma, stroke, anxiety, rheumatism, claudication, osteoporosis, chronic bronchitis and
emphysema. After multivariate adjustments were done, at the start of CR, the significant predictors of new onset
depressive symptoms were physical inactivity, high HADS anxiety score measurement, increased weight, total number
of comorbidities, diabetes, stroke, chronic back problems, being from areas with higher levels of social deprivation,
being single, and male.
Conclusion: The research findings establish new insights into the association between patient demographic and
clinical variables across a range of comorbidities in patients with new onset post heart event depressive symptoms. At
the start of CR, patients with new onset depressive symptoms need to be assessed skilfully as they tend to have a
complex multi-morbid presentation linked to psychosocial risk factors known to hinder CR engagement.
Keywords: Cardiovascular disease, Cardiac rehabilitation, Depression, New onset depressive symptoms, Comorbidities,
Observational study
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Background
Depression is common after cardiovascular disease (CVD)
and is associated with worse prognosis and increased mor-
tality rates [1]. Nearly 20% of patients experience major
depression after an acute heart event [2]. The co-
occurrence of cardiovascular disease and depression is of
concern to health care providers and commissioners con-
sidering its association with increased health care utilisa-
tion costs and hospital readmission rates [3]. Depression
is also associated with treatment noncompliance, loss of
productivity, and disability in patients with CVD [4].
Cardiac rehabilitation (CR) is a multicomponent
programme which aims for secondary prevention as
well as improving patients’ psychosocial health [5]. CR
is effective and recommended for CVD patients accord-
ing to a recent Cochrane review [6]. In addition, some
meta-analyses have shown that CR reduces depressive
symptoms [7, 8]. Recent CR and prevention guidelines
recommend the assessment of depression under the
virtue of being a multicomponent intervention and as a
risk factor for poor medical outcomes in CVD patients
[1, 5, 9, 10]. In pursuance of the management of psy-
chosocial health, in the UK, the Hospital Anxiety and
Depression Scale (HADS) is used at baseline CR to
make adjustments to the intervention based on patient
requirements and individual goals [11]. Furthermore,
HADS is a reliable and validated tool for the assess-
ment of depressive symptoms in CVD patients in differ-
ent countries including the UK [12, 13].
Recent studies are particularly focused on the time on-
set of depressive symptoms in relation to adverse cardiac
events and mortality outcomes [14–17]. Some studies
have shown that patients with history of depression prior
to a heart event had increased cardiac morbidity and risk
for mortality [14, 15], however, other research has
shown that new onset depressive symptoms after a heart
event was particularly related to increased mortality and
adverse cardiac events [16, 17]. A recent paper using
NACR data further developed this literature and found
that patients with prior history of depression and who
present with high level of depressive symptoms at the
start of CR tend to have increased weight, BMI, anxiety
symptoms, smoking, physical inactivity, and they were
younger and more likely to be single compared to pa-
tients who have depression history but absence of de-
pressive symptoms at the start of CR [18]. This study
aims to build on the previous work done in this field
with a unique population yet to be addressed, patients
without history of depression, meaning patients with
new onset post heart event depressive symptoms, to
examine which patient characteristics are associated with
developing new onset depressive symptoms in relation
to cardiovascular disease. Therefore, this study examines
the demographic and clinical characteristics associated
with new onset depressive symptoms in patients attend-
ing CR. In addition, prior studies were unable to include
different types of comorbidities and examine their asso-
ciation with depressive symptoms in CR patients which
have been included in this study. Thus, this study is the
first to further investigate the comorbidity profile of pa-
tients to enable CR practitioners to better understand
the patient profile and association of a variety of comor-
bidities at baseline, prior to the start of CR, with new
onset depressive symptoms in the UK CR context.
Methods
This study used a robust retrospective observational
methodology to examine the association of medical co-
morbidities and individual patient characteristics with
new onset depressive symptoms in CVD patients attend-
ing a CR assessment. This study has been reported ap-
plying the strengthening the reporting of observational
studies in epidemiology (STROBE) checklist [19].
Data collection
The analysis was conducted using patient data in the
NACR database. The NACR aims to monitor CR ser-
vices and improve the quality of UK CR programmes. In
order to realize this aim individual patient level data are
collected by CR programmes under section 251 approval
of the NHS Act 2006 and entered into a secure online
system hosted by NHS digital. NHS digital has approval
to collect identifiable patient data which are then anon-
ymised before data can be extracted and made available
to the NACR for audit purposes. Therefore, there was
no need to gain patient consent from individuals due to
this data governance process. Data governance agree-
ment between NHS Digital and NACR is reviewed every
year by NHS digital. In the current study as the data is
used in line with the NACR purposes and complies with
data protection regulations, no separate NHS ethical ap-
proval was required. There are 229 CR services entering
the data electronically which is 80% of all programmes
[11]. The data includes patients’ initiating event, demo-
graphics, risk factors, treatment, medication and out-
comes who undergo CR in the UK.
Participants
The NACR data between the dates – 1 April 2012 to 31
March 2018 – were extracted and analysed. The study
population included patients with myocardial infarction
(MI) and heart failure (HF) and those who receive treat-
ment of percutaneous coronary intervention (PCI) and
coronary artery bypass graft (CABG) as recommended in
the clinical guidelines [20, 21]. From the overall popula-
tion of NACR cohort (N = 277,521), 152,068 patients
(55%) had their HADS measurements recorded. All the
eligible patients (N = 109,055) who had baseline HADS
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assessments recorded in CR, and who did not present
with prior history of depression, were selected as partici-
pants during the study period.
Measures
Patients who had no reported prior history of depression
and possessed a HADS measurement at the start of CR
were screened through the NACR data set. This ap-
proach defined the eligible population that constituted
our study sample.
Hospital anxiety and depression scale
The HADS is an assessment tool consisting of self-an-
swered questions which is used for the measurement of
depressive symptoms. Psychosocial health measurements,
including HADS, are recommended to be assessed pre
and post CR to adjust CR services to the participants [5].
There are overall 14 items in HADS, 7 of the items cover
anxiety symptoms and the remaining 7 covers depression.
Every item is scored between 0 and 3, meaning separate
anxiety and depression scales can be scored between 0
and 21. HADS is a reliable and valid measure for the as-
sessment of depression and anxiety symptoms not only in
general population but also in CVD patients [12, 13, 22].
HADS depression measurement, assessed at the start of
CR, employed for the analysis and the clinical cut off point
of 8 was used to categorize patients into absence of new
onset depressive symptoms (< 8) and presence of new on-
set depressive symptoms (≥ 8) groups [13]. Afterwards,
participants with HADS < 8 and HADS ≥8 were compared
with the analysis in patients with no history of depression.
HADS anxiety scores of the patients with absence and
presence of new onset depressive symptoms were also
compared. The HADS and other measurements were
explained in detail elsewhere [18].
Total number of comorbidities and comorbidity types
Total number of comorbidities variable is calculated as
the sum of the number of comorbidities present in a
patient. Comorbidities defined as the medical history of
conditions in the NACR data which is confirmed by CR
providers. The comorbidities included in the current
study are hypertension, hypercholesterolemia, diabetes,
angina, arthritis, osteoporosis, asthma, chronic bronchitis,
emphysema (COPD), cancer, rheumatism, stroke, claudi-
cation, chronic back problems, anxiety, family history of
heart disease and erectile dysfunction.
Other variables
Age, gender, marital status (partnered/single) were the
patient demographics used in the analysis. In addition,
another patient demographic was The English Index of
Multiple Deprivation (IMD) which is a measure of
deprivation applied in England. Seven domains are used
to construct IMD measure: employment, health deprivation
and disability, income, crime, barriers to housing and ser-
vices, living environment, education skills and training [23].
There are 32,844 sub-areas ranked from the most to least
deprived areas. In our analyses, IMD was used to categorise
patients into two quintiles where first quintile, reported as
‘lowest quintile’, represents the most deprived areas and
other quintiles categorised as the less deprived. Smoking
variable was categorised to current smoker or non-smoker.
Other variables were, weight (kg), body mass index (BMI),
moderate physical activity (150min a week), and vigorous
physical activity (75min a week). Preliminary baseline
assessments and the literature search were decisive for the
inclusion of these variables. These variables have been
explained in detail in a previous publication [18].
Statistical analysis
The data was analysed using the IBM statistical package
for social sciences (SPSS) software statistics version 25
(New York, USA). Patients without prior history of de-
pression who have new onset pre HADS assessments
constituted the study population. A p value of ≤0.05 was
considered to be statistically significant. Means, standard
deviations, and percentages were used to present sum-
mary statistics. T-tests were employed to investigate the
mean difference for presence of new onset depressive
symptoms and absence of new onset depressive symp-
toms grouped by age, total number of comorbidities,
weight, BMI, and HADS anxiety. Chi-square tests were
used to investigate the association between new onset
depressive symptoms and smoking, gender, IMD, phys-
ical activity, marital status, and variety of comorbidities.
Effect sizes were reported as Cohen’s d for continuous
variables and phi for categorical variables. A binary lo-
gistic regression was conducted to examine the statisti-
cally significant predictors of new onset depressive
symptoms (HADS ≥8) at the start of CR in multivariate
analysis.
Results
A total of 109,055 patients without prior history of
depression who had started CR with valid pre HADS
assessments constituted the study population. Of these
109,055 participants 20% were present with new onset
depressive symptoms (HADS≥8) and 80% had absence
of new onset depressive symptoms (HADS< 8). The total
population during the study time period and the study
sample size has been shown in the flow diagram in Fig. 1.
Baseline characteristics of patients according to their
HADS levels (HADS≥8 presence of new onset depressive
symptoms, HADS< 8 absence of new onset depressive
symptoms) are presented in Table 1.
Participants with new onset depressive symptoms
group had a higher total number of comorbidities,
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increased anxiety scores, higher BMI, increased weight,
and were younger compared to those with an absence of
new onset depressive symptoms group.
In addition, patients with new onset depressive symp-
toms at the start of CR were more likely to be female,
physically inactive, more likely to smoke, be from areas
with higher social deprivation and single. Chi-square test
results are shown in Table 2.
Once the comorbidity profile of the patients has been
investigated, at baseline assessment, patients with pres-
ence of new onset depressive symptoms were more likely
to have the medical comorbidities of angina, arthritis,
diabetes, rheumatism, stroke, osteoporosis, chronic
bronchitis, emphysema, asthma, claudication, chronic
back problems, and anxiety compared to patients with
absence of new onset depressive symptoms. However,
patients with new onset depressive symptoms were less
likely to have cancer, family history of CVD and hyper-
cholesterolemia. The comorbidity profile of patients at-
tending CR are shown in Table 3.
A binominal logistic regression was performed to as-
certain the impact of comorbidities and other patient
characteristics on the likelihood of having new onset de-
pressive symptoms. The logistic regression model was
statistically significant, X2(12) = 12,429.216, p < 0.001.
The model correctly classified 84.9% of the cases. The
statistically significant variables were HADS anxiety
score measurement, physical activity, weight, age, gen-
der, marital status, IMD, diabetes, stroke, chronic back
problems and total number of comorbidities. Table 4
shows the regression model.
Increased HADS anxiety score measurement was asso-
ciated with having new onset depressive symptoms at
the start of CR (OR 1.443, 95% CI: 1.422, 1.445). CR par-
ticipants who are physically inactive had 87% increased
odds of having new onset depressive symptoms. (OR
1.870, 95% CI: 1.761, 1.985). Comorbidity of stroke, dia-
betes and chronic back problems were associated with
presence of new onset depressive symptoms (OR 1.543,
95% CI: 1.363, 1.745; OR 1.297, 95% CI: 1.209, 1.392;
OR 1.095, 95% CI: 1.000, 1.198 respectively) as well as
higher total number of comorbidities (OR 1.029, 95% CI:
1.008, 1.051). In addition, CR patients from the areas of
highest level of deprivation were 27% more likely to have
new onset depressive symptoms at the start of CR (OR
1.270, 95% CI: 1.169, 1.378) and males were 25% more
likely to have depressive symptoms (OR 1.254, 95% CI:
1.170, 1.344).
Discussion
Previous studies have shown the association of new on-
set depressive symptoms with major adverse cardiac
events and mortality. However, previously which factors
Fig. 1 A flow diagram for study sampling
Table 1 Baseline characteristics with t-tests for mean difference for presence and absence of new onset HADS depressive symptoms
groups
Variables HADS < 8 group (n = 87,282) HADS ≥ 8 group (n = 21,773) Difference 95% CI P d
Mean ± SD Mean ± SD
Age 66.24 ± 10.96 64.01 ± 11.69 −2.23 − 2.40 to − 2.06 < 0.001 0.20
Total Comorbidities 2.36 ± 1.46 2.60 ± 1.58 0.24 0.22 to 0.27 < 0.001 0.16
Weight 82.67 ± 16.86 83.80 ± 19.05 1.13 0.84 to 1.42 < 0.001 0.07
BMI 28.21 ± 4.97 29.00 ± 5.77 0.79 0.70 to 0.88 < 0.001 0.16
HADS Anxiety Score Measurement 4.48 ± 3.37 9.86 ± 4.12 5.38 5.33 to 5.44 < 0.001 1.52
SD standard deviation, CI confidence interval, d Cohen’s d
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are associated with new onset depressive symptoms had
not been thoroughly examined. Therefore, the current
study provides insights into the factors associated with
post heart event new onset depressive symptoms. The
findings of this study show the factors that are statisti-
cally significantly associated with new onset depressive
symptoms are higher total number of comorbidities, in-
creased weight, high HADS anxiety symptoms, physical
inactivity and variety of comorbidities. Additionally, in
terms of demographics, patients with new onset depres-
sive symptoms were more likely to be male, single and
from areas with higher social deprivation.
One finding is that patients with new onset depressive
symptoms have a higher number of total comorbidities
compared to patients with absence of depressive
symptoms after their heart event. Likewise, higher
number of comorbidities was associated with in-
creased odds of having new onset depressive symp-
toms at the start of CR after accounting for other
covariates (OR: 1.029, CI: 1.008, 1.051). In addition, a
range of comorbidities including angina, arthritis,
diabetes, rheumatism, stroke, osteoporosis, chronic
bronchitis, emphysema, asthma, anxiety, claudication,
and chronic back problems were found to be more
prevalent in patients with new onset depressive symptoms.
However, a prior RCT data driven study of Vitinius et al.
[24] was not able to find an association between comor-
bidities and depressive symptoms. This may be due to
their population being younger (mean age 59.1 ± 19.8)
in comparison to ours (65.79 ± 11.14). RCTs are known
to recruit a younger population, therefore recommen-
dations have been made for RCTs to be more inclusive
of older aged, multi-morbid populations [6]. Addition-
ally, patients with multiple comorbidities are less likely
to be referred to or uptake CR which creates challenges
for services and health care providers [25, 26]. In-
creased numbers of comorbidities may limit cardiac pa-
tients’ physical functioning and thereby increase their
depression levels [27]. However, patients with multiple
comorbidities may benefit from attending CR which
improves their functional capacity and psychosocial
conditions [26, 28].
Table 2 Results from chi square test of association for presence and absence of new onset HADS depressive symptoms groups
Variables HADS < 8 Group % (n = 87,282) HADS≥ 8 Group % (n = 21,773) P Effect size
Female 24.9 30.6 < 0.001 0.05
150 min. Physical Activity a Week (Yes) 44.0 26.4 < 0.001 0.14
75 min Vigorous Exercise a Week (Yes) 9.3 4.7 < 0.001 0.07
Smoking (Yes) 6.6 11.8 < 0.001 0.08
Partnered 78.2 72.7 < 0.001 0.05
IMD (Most deprived) 11.4 18.0 < 0.001 0.08
Table 3 The comorbidity profile of patients reported by the presence and absence of depressive symptoms groups
Comorbidity HADS < 8 Group % (n = 87,282) HADS≥ 8 Group % (n = 21,773) P Effect size
Angina 18.6 19.5 0.004 0.01
Arthritis 16.3 18.9 < 0.001 0.03
Cancer 7.8 7.2 0.003 0.01
Diabetes 20.5 26.7 < 0.001 0.06
Rheumatism 2.6 3.7 < 0.001 0.03
Stroke 4.5 6.6 < 0.001 0.04
Osteoporosis 2.1 2.7 < 0.001 0.02
Hypertension 49.5 49.8 0.43 0
Chronic bronchitis (COPD) 2.6 4.2 < 0.001 0.04
Emphysema 2.0 3.1 < 0.001 0.03
Asthma 8.4 10.4 < 0.001 0.03
Claudication 2.5 3.7 < 0.001 0.03
Chronic back problems 11.4 14.3 < 0.001 0.04
Anxiety 2.7 5.2 < 0.001 0.06
Family history of CVD 24.8 21.6 < 0.001 0.03
Erectile dysfunction 4.9 5.2 0.08 0.01
Hypercholesterolemia 28.8 27.9 0.006 0.01
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Diabetes is one of the most prevalent comorbid condi-
tion in patients with new onset depression in our sam-
ple. In addition, the current study has shown that
diabetes was associated with 29% increased odds of hav-
ing new onset depressive symptoms in CR attenders
(OR: 1.297 95% CI: 1.209, 1.392). At the start of CR, dia-
betic patients presented with more cardiovascular risk
factors and had reduced physical fitness [29]. The posi-
tive impact of CR in patients with diabetes has been in-
vestigated by previous studies in terms of mortality [30,
31]. Due to having a greater cardiac risk profile and
lower programme uptake rate, CR programmes are rec-
ommended to target patients with diabetes [32–34].
Given that the prevalence of diabetes is continuing to
rise [35], the medical management of diabetes may be
relevant and lead to a reduction in depressive symptoms.
For each percent increase in the proportion of patients
with stroke comorbidity, the odds of being in the new
onset depressive symptoms category increases by a fac-
tor of 1.543 compared to absence of new onset depres-
sive symptoms. The presence of stroke comorbidity is
associated with a lower likelihood of a patient being re-
ferred to [25], and uptake CR [26]. Yet, stroke patients
can benefit from CR programmes in terms of improve-
ments in their cardiovascular fitness and functional cap-
acity [36], therefore involvement of these patients into
CR can be of benefit.
Our study has shown that respiratory related condi-
tions such as chronic bronchitis, emphysema and asthma
were associated with new onset depressive symptoms in
baseline univariate analysis. Patients with CVD and
COPD experience problems of breathlessness and dis-
ability, therefore cardiac rehabilitation services are rec-
ommended to provide sufficient flexibility to be inclusive
of patients with COPD [37]. The comorbidities of arth-
ritis, rheumatism, osteoporosis and back pain were also
associated with increased depressive symptoms after
heart event. The findings of a cohort study has shown
that, at baseline CR assessments, patients having these
comorbid conditions had a poorer health profile such as
lack of physical activity and fitness than those who do
not present with these comorbidities [38] which may be
responsible from their increased levels of depression. In-
deed, in the current study, the comorbidity of chronic
back pain was associated with increased odds of having
new onset depressive symptoms in patients commencing
CR (OR 1.095, 95%CI: 1.000, 1.198). This study is the
first to shed a light upon the variety of comorbidities
and their association with new onset depressive symp-
toms among patients attending CR.
BMI was statistically significantly higher among pa-
tients with new onset depressive symptoms group with
difference of 0.79 compared to patients with absence of
new onset depressive symptoms, whereas they were in
the same range of being overweight (BMI 29.00 vs
28.21). However, this statistically significant finding have
not been observed in a USA based CR study [28], the
reason for this might be that this American study have
not factored in the patients with new onset depressive
symptoms whose characteristics may be different. Pa-
tients with new onset depressive symptoms had also in-
creased weight by 1.13 kilogrammes compared to
patients with absence of new depressive symptoms
group in the current study. In addition, in multivariate
analysis, weight measurement remained to be signifi-
cantly associated with new onset depressive symptoms
after adjusting for other covariates.
The association of anxiety with depressive symptoms
is confirmed by this study. The mean HADS anxiety
scores were both statistically significant and clinically
meaningfully higher in patients with new onset depres-
sive symptoms group compared to absence of new onset
Table 4 Multivariable adjusted odds ratios for new onset depressive symptoms
Variable B SE Odds Ratio Lower 95% CI for Odds Ratio Upper 95% CI for Odds Ratio
Age 0.009 0.001 1.009 1.006 1.012
Weight 0.002 0.001 1.002 1.000 1.004
HADS anxiety score measurement .360 0.004 1.443 1.422 1.445
150min. a week physical activity (No) 0.626 0.031 1.870 1.761 1.985
Smoking (Yes) 0.097 0.052 1.102 0.995 1.221
Gender (Male) 0.227 0.035 1.254 1.170 1.344
Marital Status (Single) 0.138 0.034 1.148 1.074 1.227
Diabetes (Yes) 0.260 0.036 1.297 1.209 1.392
Stroke (Yes) 0.434 0.063 1.543 1.363 1.745
Chronic back problems (Yes) 0.091 0.046 1.095 1.000 1.198
Total number of comorbidities 0.029 0.011 1.029 1.008 1.051
IMD (Most deprived) 0.239 0.042 1.270 1.169 1.378
B regression coefficient, SE standard error, CI confidence interval for odds ratio
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depression (MD:5.38 (95%CI 5.33 to 5.44)). A recent
study of Lemay et al. 2019 has shown that minimum
clinically important difference in HADS is 1.7 for CR pa-
tients [39]. The mean difference among these groups
were more than threefold higher than the minimal clin-
ically important difference.
One clinically relevant finding was that smoking and
physical inactivity were two of the modifiable cardiac
risk factors that were associated with new onset depres-
sion. These results support previous systematic reviews
conducted in the general population which show the
prospective association between physical activity and
smoking with depression [40, 41], and some cohort stud-
ies that were unable to differentiate new onset depres-
sive symptoms in cardiac populations [42–44]. Our
findings have added that at baseline CR assessments pa-
tients who present with new onset post heart event de-
pression are more likely to smoke and be physically
inactive compared to patients with absence of new onset
depression. In addition in multivariable analysis physical
inactivity was statistically significantly associated with
87% increased odds of having new onset depressive
symptoms at baseline CR (OR 1.870, 95% CI: 1.761,
1.985). However, smoking was unable to reach the statis-
tical significance in the regression model.
The patient demographics associated with new onset
depressive symptoms were being single, which was in
line with previous studies [45], male gender and being
older. The English Index of Multiple Deprivation (IMD)
was also one of the demographic measures included in
the current study. A recent USA based study has shown
that lower neighbourhood socioeconomic context, mea-
sured by neighbourhood deprivation index, was associ-
ated with reduced likelihood of CR uptake [46].
However, our study used the IMD measure and is the
first to show that patients with new onset depressive
symptoms attending CR were more likely to be from
areas with higher levels of social deprivation. This asso-
ciation of increased social deprivation with new onset
depressive symptoms remained significant after adjusting
for other covariates by having 27% increased odds of
presenting with new onset depressive symptoms (OR
1.270, 95%CI: 1.169, 1.378). Deprivation is associated
with poor health behaviours such as smoking and phys-
ical inactivity [47] which might be responsible for their
depressive symptoms initiation. Patients from areas with
greater deprivation can be more disadvantaged naturally
and experience barriers to attending CR [46] therefore
strategies for inclusion of this patient group appears to
be a natural next step. In addition, screening depressive
symptoms in patients from areas of higher levels of
deprivation that attend CR may be of benefit for early
detection of the patients with high risks which perhaps
could be investigated in the future studies.
Our findings are in line with the European Society of
Cardiology (ESC) Position statement on psychosocial as-
pects of cardiac rehabilitation supporting that patients
with low socioeconomic status or from areas of higher
deprivation are more likely to have depressive symptoms
which may lead to poor prognosis of their CVD [48].
We agree that it is important for CR programmes to
identify patients with new onset depressive symptoms or
other psychosocial risk factors and offer tailored inter-
ventions to these patients by a trained health care pro-
fessionals [48].
Limitations
Our population excluded patients with prior history of
depression. This is because we aimed to investigate the
factors associated with new onset depressive symptoms.
However, when we examined the characteristics of our
sample, it was representative of all available patients dur-
ing the study time period ((n = 277,521), mean age was
65.79 compared to 65.06, 26% female compared to 27%,
and this proportion did not differ by more than 4% for
other variables). The study sample was nationally repre-
sentative of patients with new onset depressive symp-
toms in the UK. The use of an observational approach
enabled us to generate real world understanding by ana-
lysing routinely collected clinical data. The data included
more patients with multi-comorbidities and higher fe-
male proportion than prior RCTs [6]. However, due to
the nature of an observational study, causal conclusions
cannot be drawn.
Conclusion
According to the results of multivariate analysis, the
characteristics that associated with new onset depressive
symptoms were having higher total number of comor-
bidities, diabetes, stroke, chronic back problems, in-
creased weight, physical inactivity, high anxiety scores,
being male, single and from areas of greater deprivation.
At baseline assessment, CR programmes need to ac-
knowledge that patients with new onset depressive
symptoms may need tailored CR intervention due to
their multi-morbid medical condition and poor patient
characteristics including physical inactivity, high anxiety
scores, increased weight and others. Further studies need
to focus on patient outcomes related to new onset de-
pressive symptoms.
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